Komori
Mochida Pharmaceutical (4534) · InitiativeRestated

Stable Supply, Quality Maintenance and Cost Structure Improvement

First written in FY2024. 1 of 3 entries say "Restated". Latest entry: FY2026.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024 – FY20262024: 120242025: 120252026: 12026
Same theme, other companies
Ongoing Supply of Safe, Reliable, High-Quality ProductsA theme 36 companies write about · 0 as a headwind · 36 as a tailwind

The whole theme swung hardest in 2024: 2 of 22 companies on the "Worse" side.

19 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 36 companies compared. The sentences above are computed from all 36.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Stable Supply, Quality Maintenance and Cost Structure Improvement | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori